Titan Pharmaceuticals Inc.
TTNP | NASDAQ
$2.34
-$0.30 (-11.36%)
At close: Dec 16, 2025, 1:46 PM ET
TTM Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 | Q4 2020 Dec 31, 2020 | Q3 2020 Sep 30, 2020 | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -2.49M | -2.85M | -2.81M | -4.21M | -4.71M | -5.89M | -5.46M | -4.95M | -5.57M | -6.17M | -8.47M | -9.34M | -10.21M | -10.18M | -9.46M | -8.68M | -8.78M | -9.32M | -12.34M | -15.3M | -18.24M | -19.1M | -16.97M | -17.53M |
Depreciation & Amortization | n/a | n/a | n/a | 3K | 5K | 8K | 35K | 71K | 112K | 154K | 175K | 187K | 196K | 204K | 212K | 218K | 221K | 233K | 276K | 285K | 292K | 285K | 249K | 246K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | 48K | 459K | 723K | 1.01M | 874K | 1M | 1.03M | 997K | 1.27M | 1.39M | 1.55M | 1.54M | 1.36M | 707K | 339K | 7K | -38K | 81K | 352K |
Other Working Capital | -799K | 96K | 158K | 116K | -78K | -694K | -628K | -432K | -448K | 553K | 514K | 847K | 922K | 315K | -301K | -354K | -322K | -1.6M | 69K | -757K | -556K | 626K | -791K | -482K |
Other Non-Cash Items | n/a | 11K | -59K | -51K | -356K | 95K | -358K | -48K | 381K | 664K | 1.48M | 1.12M | 747K | 298K | 5K | 50K | -5K | -171K | -27K | 122K | 482K | 2.08M | 730K | 773K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -166K | -1.38M | -1.69M | -2.11M | -1.95M | -737K | -428K | n/a | n/a | n/a | -661K | -661K | -2.78M | -2.34M | -1.68M | -760K | 20K | -413K | -413K |
Change in Working Capital | -924K | 38K | 59K | 73K | 823K | 211K | -61K | 87K | -916K | -5K | 373K | 601K | 378K | 1.02M | -227K | -716K | -219K | -705K | 1.16M | 1.62M | 1.02M | 446K | 139K | 218K |
Operating Cash Flow | -3.41M | -2.81M | -2.75M | -4.13M | -3.88M | -5.62M | -6.76M | -5.81M | -7.09M | -6.43M | -6.46M | -7.12M | -8.18M | -7.69M | -8.07M | -8.24M | -7.9M | -11.38M | -12.56M | -14.62M | -17.2M | -16.31M | -16.18M | -16.35M |
Capital Expenditures | -5K | -5K | n/a | n/a | n/a | -2K | -2K | -2K | -2K | n/a | n/a | n/a | n/a | -5K | -5K | -23K | -23K | -27K | -471K | -510K | -540K | -643K | -260K | -242K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 506K | 734K | 734K | 734K | 228K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -3.16M | n/a | n/a | n/a | n/a | 506K | 734K | 734K | 734K | 228K | n/a | n/a | n/a | -23K | -23K | -23K | -23K | -540K | -540K | -540K | -540K | -267K | -267K | -267K |
Investing Cash Flow | -3.16M | -5K | n/a | n/a | n/a | 504K | 732K | 732K | 732K | 228K | n/a | n/a | n/a | -5K | -5K | -23K | -23K | -27K | -471K | -510K | -540K | -643K | -260K | -242K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.47M | -232K | -143K | -81K | -62K | n/a | 9.59M | 9.59M | 9.59M | 9.59M | n/a | 3K | 4K | 8.85M | 8.85M | 8.84M | 8.84M | -1.39M | -1.37M | 135K | 6.3M | 8.56M | 8.56M | 7.16M |
Financial Cash Flow | 4.07M | 1.37M | 1.46M | -81K | -62K | 406K | 10M | 10M | 10M | 9.59M | n/a | 3K | 4.98M | 4.98M | 4.98M | 4.98M | 8.84M | 14.75M | 17.22M | 18.72M | 17.93M | 20.1M | 19.65M | 18.72M |
Net Cash Flow | -2.5M | -1.44M | -1.29M | -4.21M | -3.94M | -4.71M | 3.97M | 4.93M | 3.64M | 3.4M | -6.46M | -7.12M | -3.2M | -2.71M | -3.1M | -3.28M | 919K | 3.35M | 4.18M | 3.59M | 190K | 3.15M | 3.21M | 2.13M |
Free Cash Flow | -3.41M | -2.81M | -2.75M | -4.13M | -3.88M | -5.62M | -6.76M | -5.81M | -7.09M | -6.43M | -6.46M | -7.12M | -8.18M | -7.69M | -8.08M | -8.26M | -7.92M | -11.41M | -13.04M | -15.13M | -17.74M | -16.95M | -16.44M | -16.59M |
Adj. Free Cash Flow | -3.41M | -2.81M | -2.75M | -4.13M | -3.88M | -5.67M | -7.22M | -6.53M | -8.11M | -7.3M | -7.47M | -8.15M | -9.18M | -8.96M | -9.47M | -9.81M | -9.46M | -12.77M | -13.74M | -15.47M | -17.75M | -16.91M | -16.52M | -16.94M |
Maintenance CapEx | -5K | -5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | -5K | -23K | -23K | -27K | -438.78K | -420.78K | -420.78K | -411.78K | -61K | -100K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -2K | -2K | -2K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -32.22K | -89.22K | -119.22K | -231.22K | -199K | -142K |
Owner Earnings | -3.41M | -2.81M | -2.75M | -4.13M | -3.88M | -5.62M | -6.76M | -5.81M | -7.09M | -6.43M | -6.46M | -7.12M | -8.18M | -7.69M | -8.08M | -8.26M | -7.92M | -11.41M | -13M | -15.04M | -17.62M | -16.72M | -16.24M | -16.45M |
Add to Watchlist
Select watchlists to add or remove TTNP